相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The impact of belatacept on third-party HLA alloantibodies in highly sensitized kidney transplant recipients
Ronald F. Parsons et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
OPTN/SRTR 2018 Annual Data Report: Intestine
J. M. Smith et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
OPTN/SRTR 2018 Annual Data Report: Pancreas
R. Kandaswamy et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
OPTN/SRTR 2018 Annual Data Report: Lung
M. Valapour et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
OPTN/SRTR 2018 Annual Data Report: Heart
M. Colvin et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
OPTN/SRTR 2018 Annual Data Report: Kidney
A. Hart et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
OPTN/SRTR 2018 Annual Data Report: Liver
A. Kwong et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group
Carrie A. Schinstock et al.
TRANSPLANTATION (2020)
Induction immunosuppression strategies and long-term outcomes after heart transplantation
Shahab Nozohoor et al.
CLINICAL TRANSPLANTATION (2020)
The evolving role of regulatory reporting on patient and donor selection in organ transplantation
Jesse D. Schold
CURRENT OPINION IN ORGAN TRANSPLANTATION (2020)
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials
Birgit Sawitzki et al.
LANCET (2020)
The Use of Donor-Derived Cell-Free DNA for Assessment of Allograft Rejection and Injury Status
Charat Thongprayoon et al.
JOURNAL OF CLINICAL MEDICINE (2020)
BK polyomavirus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
Hans H. Hirsch et al.
CLINICAL TRANSPLANTATION (2019)
Use of Eculizumab for Active Antibody-mediated Rejection That Occurs Early Post-kidney Transplantation: A Consecutive Series of 15 Cases
Ek Khoon Tan et al.
TRANSPLANTATION (2019)
Safety and efficacy of eculizumab for the prevention of antibody-mediated rejection after deceased-donor kidney transplantation in patients with preformed donor-specific antibodies
Denis Glotz et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Novel Therapeutic Approaches to Allosensitization and Antibody-mediated Rejection
Stanley C. Jordan et al.
TRANSPLANTATION (2019)
Long-term outcomes of eculizumab-treated positive crossmatch recipients: Allograft survival, histologic findings, and natural history of the donor-specific antibodies
Carrie A. Schinstock et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Rabbit anti-thymocyte globulin for the prevention of acute rejection in kidney transplantation
Rita R. Alloway et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized trial
William H. Marks et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection
Farsad Eskandary et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
De novo donor-specific antibodies in belatacept-treated vs cyclosporine-treated kidney-transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT-EXT studies
R. A. Bray et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
IdeS (Imlifidase): A Novel Agent That Cleaves Human IgG and Permits Successful Kidney Transplantation Across High-strength Donor-specific Antibody
Bonnie E. Lonze et al.
ANNALS OF SURGERY (2018)
Contemporary Strategies and Barriers to Transplantation Tolerance
Brian Ezekian et al.
TRANSPLANTATION (2018)
Belatacept in Solid Organ Transplant: Review of Current Literature Across Transplant Types
Caroline P. Perez et al.
TRANSPLANTATION (2018)
Delayed calcineurin inhibitor introduction and renal outcomes in liver transplant recipients receiving basiliximab induction
Nicholas W. Lange et al.
CLINICAL TRANSPLANTATION (2018)
Solid organ transplantation in the 21st century
Cara K. Black et al.
ANNALS OF TRANSLATIONAL MEDICINE (2018)
Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: A multicenter, prospective, randomized, double-blind clinical trial
Francesc Moreso et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
Understanding Trends in Kidney Function 1 Year after Kidney Transplant in the United States
Yihung Huang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation
S. C. Jordan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Assessment of Tocilizumab (Anti-Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipients
J. Choi et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Proteasome Inhibitor Carfilzomib-Based Therapy for Antibody-Mediated Rejection of the Pulmonary Allograft: Use and Short-Term Findings
C. R. Ensor et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Immunosuppression Minimization and Avoidance Protocols: When Less Is Not More
Rohini Prashar et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2016)
Plasma-Derived C1 Esterase Inhibitor for Acute Antibody-Mediated Rejection Following Kidney Transplantation: Results of a Randomized Double-Blind Placebo-Controlled Pilot Study
R. A. Montgomery et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Long-Term Outcomes in Belatacept- Versus Cyclosporine-Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT-EXT, a Phase III Randomized Study
A. Durrbach et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
C1 Inhibitor in Acute Antibody-Mediated Rejection Nonresponsive to Conventional Therapy in Kidney Transplant Recipients: A Pilot Study
D. Viglietti et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Safety of mTOR inhibitors in adult solid organ transplantation
Pedro Ventura-Aguiar et al.
EXPERT OPINION ON DRUG SAFETY (2016)
Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial
Oliver Thomusch et al.
LANCET (2016)
Belatacept and Long-Term Outcomes in Kidney Transplantation
Flavio Vincenti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients
Jacqueline G. O'Leary et al.
TRANSPLANTATION (2016)
One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation: RITUX ERAH, a Multicenter Double-blind Randomized Placebo-controlled Trial
Benedicte Sautenet et al.
TRANSPLANTATION (2016)
Positive Crossmatch Kidney Transplant Recipients Treated With Eculizumab: Outcomes Beyond 1 Year
L. D. Cornell et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
New-Onset Diabetes After Transplantation: Results From a Double-Blind Early Corticosteroid Withdrawal Trial
J. D. Pirsch et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
A Phase I/II Trial of the Interleukin-6 Receptor Specific Humanized Monoclonal (Tocilizumab) plus Intravenous Immunoglobulin in Difficult to Desensitize Patients
Ashley A. Vo et al.
TRANSPLANTATION (2015)
Impact of induction immunosuppression on survival in heart transplant recipients: a contemporary analysis of agents
Bryan A. Whitson et al.
CLINICAL TRANSPLANTATION (2015)
Thymoglobulin induction in heart transplantation: patient selection and implications for maintenance immunosuppression
Andreas Zuckermann et al.
TRANSPLANT INTERNATIONAL (2015)
Alemtuzumab in Lung Transplantation: An Open-Label, Randomized, Prospective Single Center Study
P. Jaksch et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
To induce or not to induce: a 21st century evaluation of lung transplant immunosuppression's effect on survival
Bryan A. Whitson et al.
CLINICAL TRANSPLANTATION (2014)
OPTN/SRTR 2011 Annual Data Report: Lung
M. Valapour et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
OPTN/SRTR 2011 Annual Data Report: Heart
M. Colvin-Adams et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
OPTN/SRTR 2011 Annual Data Report: Kidney
A. J. Matas et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
OPTN/SRTR 2011 Annual Data Report: Liver
W. R. Kim et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Historical Overview of Transplantation
Clyde F. Barker et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients
M. D. Stegall et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Alemtuzumab Induction in Renal Transplantation
Michael J. Hanaway et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Increasing Trend in Infection-Related Death-Censored Graft Failure in Renal Transplantation
Ravi Parasuraman et al.
TRANSPLANTATION (2011)
A Phase III Study of Belatacept-based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)
F. Vincenti et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials
Luit Penninga et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Antibody immunosuppressive therapy in solid-organ transplant Part I
Nadim Mahmud et al.
MABS (2010)
Immunosuppressive Drugs in Kidney Transplantation Impact on Patient Survival, and Incidence of Cardiovascular Disease, Malignancy and Infection
Roberto Marcen
DRUGS (2009)
Trends in kidney transplantation over the past decade
Greg Knoll
DRUGS (2008)
Immunosuppression: Evolution in practice and trends, 1994-2004
HU Meier-Kriesche et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: Results at 1 year
R Mendez et al.
TRANSPLANTATION (2005)
Antibody induction therapy in renal transplant patients receiving calcineurin-inhibitor immunosuppressive regimens - A comparative review
B Nashan
BIODRUGS (2005)
The use of cyclosporine in renal transplantation
DA Hesselink et al.
TRANSPLANTATION PROCEEDINGS (2004)
Everolimus (Certican) 12-month safety and efficacy versus mycophenolate mofetil in de novo renal transplant recipients
S Vitko et al.
TRANSPLANTATION (2004)
Mycophenolate mofetil in solid-organ transplantation
TR Srinivas et al.
EXPERT OPINION ON PHARMACOTHERAPY (2003)
Tacrolimus - A further update of its use in the management of organ transplantation
LJ Scott et al.
DRUGS (2003)
Immunosuppression: practice and trends
JH Helderman et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2003)
Basifiximab - A review of its use as induction therapy in renal transplantation
TM Chapman et al.
DRUGS (2003)
分享论文
